In-vivo Proliferative potential of primary human brain tumors; its correlation with histological classification and morphological features: I gliomas

Pathology ◽  
1993 ◽  
Vol 25 (1) ◽  
pp. 4-9 ◽  
Author(s):  
Amit K. Dinda ◽  
Kusum Kharbanda ◽  
Chitra Sarkar ◽  
Subimal Roy ◽  
Meera Mathur ◽  
...  
1988 ◽  
Vol 69 (3) ◽  
pp. 371-374 ◽  
Author(s):  
Takafumi Nishizaki ◽  
Tetsuji Orita ◽  
Masahide Saiki ◽  
Yasuhiro Furutani ◽  
Hideo Aoki

✓ Since the development of a specific monoclonal antibody against the thymidine analogue bromodeoxyuridine (BUdR), many investigators have used intravenous infusion of BUdR to estimate the proliferative potential of human brain tumors. However, side effects such as the induction of cell mutation, latent virus promotion, or inhibition of cytodifferentiation cannot be ignored, and thus many workers hesitate to use it in patients, especially those with hepatic disease or of reproductive age. Furthermore, if BUdR remains in the deoxyribonucleic acid of tumor cells after injection, analysis of the effect of chemical and radiation therapy may not be evaluated correctly. In this report, in vitro BUdR labeling with an anti-BUdR antibody is compared with the in vivo methods described by previous authors. This method appears to be useful for determining the S-phase fraction of human brain tumor. It was more rapid, and was simple, safe, and reproducible as compared to the intravenous infusion method.


Brain Tumor ◽  
1996 ◽  
pp. 237-245 ◽  
Author(s):  
Kiyonobu Ikezaki ◽  
Ken Samoto ◽  
Takanori Inamura ◽  
Tadahisa Shono ◽  
Masashi Fukui ◽  
...  

1992 ◽  
Vol 14 (2) ◽  
Author(s):  
W.T. Ivan Yeung ◽  
Ting-Yim Lee ◽  
RolandoF. Del Maestro ◽  
Roman Kozak ◽  
Thomas Brown

2012 ◽  
Vol 25 (11) ◽  
pp. 1234-1244 ◽  
Author(s):  
Elizabeth A. Maher ◽  
Isaac Marin-Valencia ◽  
Robert M. Bachoo ◽  
Tomoyuki Mashimo ◽  
Jack Raisanen ◽  
...  

Author(s):  
V. Tugnoli ◽  
M. R. Tosi ◽  
A. Bertoluzza ◽  
G. Barbarella ◽  
R. Ricci

1993 ◽  
Vol 29 (5) ◽  
pp. 861 ◽  
Author(s):  
Bo Young Choe ◽  
Tae Suk Suh ◽  
Kyu Ho Choi ◽  
Ki Tae Kim ◽  
Kyung Sub Shinn

2019 ◽  
Vol 82 (4) ◽  
pp. 1259-1265
Author(s):  
Francesca Branzoli ◽  
Dinesh K. Deelchand ◽  
Marc Sanson ◽  
Stéphane Lehéricy ◽  
Małgorzata Marjańska

1987 ◽  
Vol 67 (3) ◽  
pp. 336-340 ◽  
Author(s):  
Terry Lichtor ◽  
George J. Dohrmann

✓ Glucose utilization in vivo and hexokinase activity and mitochondrial oxygen consumption in vitro were measured in a series of human brain tumors. Several relatively slow-growing tumors appeared to have depressed electron-transport activities coupled with a compensatory elevated glucose utilization. These data suggest that a decrease in oxidative metabolism and a corresponding increase in glycolysis are not necessarily correlated with malignancy in certain human brain tumors.


Sign in / Sign up

Export Citation Format

Share Document